NCT Number: NCT02818803
Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic
The purpose of this study is to evaluate the efficacy and safety of propolis on the treatment of oral candidiasis, more specifically denture stomatitis. Half of participants will receive a standardized-propolis (EPP-AF®) gel formulation while the other half will receive miconazole gel, both for oral use.
Looking for future studies?
Notify MeKey information
Conditions
Age range
60 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Unievangelica Anapolis, Anápolis, Goiás, Brazil
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Elderly patients with denture stomatitis
Exclusion criteria
- Recent use of anti fungals or antibiotics(2 months or less), dementia
Treatment and study plan
miconazole
DrugOther names: Daktarin oral gel
Primary outcomes
-
Change from Newton Score at 14 days
Time frame: Day 14
Clinical assessment of buccal lesions localized at hard palate. The score utilized to measure the intensity of lesions will be Newton classification (I - punctate in the palate; II - extensive smooth reddened appearance; III -extensive reddening with hyperplastic growth) and the outcome will be the reduction of Newton's score comparing day 1 with day 14.
Secondary outcomes
-
Assessment of gel acceptability
Time frame: Day 7
Application of hedonic scale on day 7
-
Assessment of adverse events
Time frame: Day 7 and 14
Questioning about rise of adverse events on days 7 and 14
-
Anti fungal activity
Time frame: Day 1 and 14
Colony forming unit count (CFU/mL) on days 1 and 14
Sponsors and collaborators
Lead sponsor
University of Sao Paulo
Other
Collaborators
- Financiadora de Estudos e Projetos
Registry information
Official study title
Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic in Elderly People
Important dates
- Study start
- 2016
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Jun 30, 2016
- Registry last updated
- Jun 30, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis
NCT06120816
Bacterial Infections and Mycoses, Candidiasis
Vancouver, British Columbia, Canada
View Trial DetailsStudy to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID
NCT00235053
Asthma, Bacterial Infections and Mycoses
San Diego, California, United States
View Trial DetailsA Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole
NCT00001065
AIDS-Related Complex, Acquired Immunodeficiency Syndrome
Birmingham, Alabama, United States
View Trial DetailsA Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush
NCT00000951
AIDS-Related Opportunistic Infections, Bacterial Infections and Mycoses
Los Angeles, California, United States
View Trial Details